{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T05:47:00Z","timestamp":1777873620537,"version":"3.51.4"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82104276"],"award-info":[{"award-number":["82104276"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82104276,82373938"],"award-info":[{"award-number":["82104276,82373938"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.jpba.2024.116083","type":"journal-article","created":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T11:25:01Z","timestamp":1709378701000},"page":"116083","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["A validated LC-MS\/MS method for the quantitation of daratumumab in rat serum using rapid tryptic digestion without IgG purification and reduction"],"prefix":"10.1016","volume":"243","author":[{"given":"Weiqiang","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wensi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yali","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donghui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feiyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinghua","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingxing","family":"Diao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2024.116083_bib1","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.tmrv.2021.06.002","article-title":"Daratumumab: beyond multiple myeloma","volume":"35","author":"Ejaz","year":"2021","journal-title":"Transfus. Med Rev."},{"key":"10.1016\/j.jpba.2024.116083_bib2","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1358\/dot.2016.52.10.2543308","article-title":"Daratumumab: monoclonal antibody therapy to treat multiple myeloma","volume":"52","author":"Xia","year":"2016","journal-title":"Drugs Today"},{"key":"10.1016\/j.jpba.2024.116083_bib3","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1080\/14712598.2017.1322578","article-title":"Daratumumab for the treatment of multiple myeloma","volume":"17","author":"Touzeau","year":"2017","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.jpba.2024.116083_bib4","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/10428194.2018.1485914","article-title":"Daratumumab for the treatment of AL amyloidosis","volume":"60","author":"Sidiqi","year":"2019","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.jpba.2024.116083_bib5","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1002\/cncr.32065","article-title":"Daratumumab in multiple myeloma","volume":"125","author":"Nooka","year":"2019","journal-title":"Cancer"},{"key":"10.1016\/j.jpba.2024.116083_bib6","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/17474086.2021.1858790","article-title":"A comprehensive overview of daratumumab and carfilzomib and the recently approved daratumumab, carfilzomib and dexamethasone regimen in relapsed\/refractory multiple myeloma","volume":"14","author":"Richard","year":"2021","journal-title":"Expert Rev. Hematol."},{"key":"10.1016\/j.jpba.2024.116083_bib7","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1080\/14712598.2020.1806231","article-title":"Daratumumab subcutaneous formulation for the treatment of multiple myeloma","volume":"20","author":"Paul","year":"2020","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.jpba.2024.116083_bib8","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1080\/17474086.2020.1795829","article-title":"An evaluation of subcutaneous daratumumab for the treatment of multiple myeloma","volume":"13","author":"Paul","year":"2020","journal-title":"Expert Rev. Hematol."},{"key":"10.1016\/j.jpba.2024.116083_bib9","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1053\/j.seminoncol.2022.01.008","article-title":"Daratumumab: a review of current indications and future directions","volume":"49","author":"Hill","year":"2022","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.jpba.2024.116083_bib10","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1177\/10600280211058754","article-title":"Daratumumab for the treatment of multiple myeloma: a review of clinical applicability and operational considerations","volume":"56","author":"Arnall","year":"2022","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.jpba.2024.116083_bib11","doi-asserted-by":"crossref","DOI":"10.1177\/2040620719894871","article-title":"Daratumumab in untreated newly diagnosed multiple myeloma","volume":"10","author":"Abdallah","year":"2019","journal-title":"Ther. Adv. Hematol."},{"key":"10.1016\/j.jpba.2024.116083_bib12","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.4155\/bio-2020-0204","article-title":"Bottom-up sample preparation for the LC\u2013MS\/MS quantification of anti-cancer monoclonal antibodies in bio matrices","volume":"12","author":"de Jong","year":"2020","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jpba.2024.116083_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2022.115188","article-title":"Development and validation of a LC\u2013MS\/MS method for quantitation of recombinant human growth hormone in rat plasma and application to a pharmacokinetic study","volume":"224","author":"Huang","year":"2023","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2024.116083_bib14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jim.2018.12.005","article-title":"Measurement of IL-21 in human serum and plasma using ultrasensitive MSD S-PLEX\u00ae and Quanterix SiMoA methodologies","volume":"466","author":"Poorbaugh","year":"2019","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jpba.2024.116083_bib15","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jpba.2018.11.033","article-title":"Reactive intermediates and bioactivation pathways characterization of avitinib by LC-MS\/MS: in vitro metabolic investigation","volume":"164","author":"Attwa","year":"2019","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2024.116083_bib16","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jpba.2022.114626","article-title":"Estimation of zorifertinib metabolic stability in human liver microsomes using LC-MS\/MS","volume":"211","author":"Attwa","year":"2022","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2024.116083_bib17","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jchromb.2019.01.032","article-title":"Intact protein bioanalysis by liquid chromatography - high-resolution mass spectrometry","volume":"1110","author":"Bults","year":"2019","journal-title":"J. Chromatogr. B."},{"key":"10.1016\/j.jpba.2024.116083_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2023.115590","article-title":"A validated LC-MS\/MS method for the quantification of bevacizumab in rat, cynomolgus monkey, and human serum","volume":"235","author":"Zhou","year":"2023","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2024.116083_bib19","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1111\/fcp.12662","article-title":"Variability of rituximab and tocilizumab trough concentrations in patients with rheumatoid arthritis","volume":"35","author":"Truffot","year":"2021","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.jpba.2024.116083_bib20","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.jpba.2018.11.019","article-title":"Acceleration of nano-surface and molecular-orientation limited (nSMOL) proteolysis with acidified reduction pretreatment for quantification of Tocilizumab","volume":"164","author":"Iwamoto","year":"2019","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2024.116083_bib21","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.jpha.2022.08.003","article-title":"LC-MS\/MS method for the quantitation of serum tocilizumab in rheumatoid arthritis patients using rapid tryptic digestion without IgG purification","volume":"12","author":"Mochizuki","year":"2022","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.jpba.2024.116083_bib22","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1093\/nar\/25.17.3389","article-title":"Gapped BLAST and PSI-BLAST: a new generation of protein database search programs","volume":"25","author":"Altschul","year":"1997","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jpba.2024.116083_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2021.114515","article-title":"Development and validation of a UPLC-MS\/MS method to quantitate anti-PD1 monoclonal antibody (Toripalimab), and comparison with electrochemiluminescence immunoassay","volume":"209","author":"Liu","year":"2022","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2024.116083_bib24","unstructured":"The International Council for Harmonisation, Bioanalytical Method Validation and Study Sample Analysis. \u3008https:\/\/www.ich.org\/page\/multidisciplinary-guidelines\u3009, (Accessed 24 May 2022)."},{"key":"10.1016\/j.jpba.2024.116083_bib25","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1023\/A:1018943613122","article-title":"Physiological-parameters in laboratory-animals and humans","volume":"10","author":"Davies","year":"1993","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jpba.2024.116083_bib26","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jpba.2019.06.017","article-title":"Simultaneous quantification of total antibody and antibody-conjugated drug for XMT-1522 in human plasma using immunocapture-liquid chromatography\/mass spectrometry","volume":"174","author":"Xu","year":"2019","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2024.116083_bib27","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ab.2017.08.024","article-title":"A generic approach for simultaneous measurements of total antibody and cleavable antibody-conjugated drug by LC\/MS\/MS","volume":"537","author":"Xu","year":"2017","journal-title":"Anal. Biochem"}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708524001237?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708524001237?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T18:06:47Z","timestamp":1777572407000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708524001237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":27,"alternative-id":["S0731708524001237"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2024.116083","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A validated LC-MS\/MS method for the quantitation of daratumumab in rat serum using rapid tryptic digestion without IgG purification and reduction","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2024.116083","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116083"}}